Israeli Biotech Company Starts Clinical Trials of CBD-Steroid Treatment for Virus | Algemeiner.com
JNS.org – The Israel-based biotech company Stero Biotechs has started a small-scale clinical trial at Rabin Medical Center’s Golda Hasharon Campus in Petach Tikvah on the effects of a steroid-Cannabidiol (CBD) treatment on hospitalized COVID-19 patients.
Leave a Reply
You must belogged in to post a comment.